Non‐invasive prenatal testing: clinical utility and ethical concerns about recent advances

• 1 Mater Health, Brisbane, QLD
• 2 Sullivan Nicolaides Pathology, Brisbane, QLD
• 3 Queensland Bioethics Centre, Australian Catholic University, Brisbane, QLD

---

• 1. Liley HG, Peek MJ, Daly J. Non‐invasive prenatal testing: clinical utility and ethical concerns about recent advances [letter]. Med J Aust 2021; 215: 000–000.
• 2. McLean A, Wu K. Non‐invasive prenatal testing: clinical utility and ethical concerns about recent advances [letter]. Med J Aust 2021; 215: 000–000.
• 3. Thomas J, Harraway J, Kirchhoffer D. Non‐invasive prenatal testing: clinical utility and ethical concerns about recent advances. Med J Aust 2021; 214: 168–170. https://www.mja.com.au/journal/2021/214/4/non‐invasive‐prenatal‐testi\ng‐clinical‐utility‐and‐ethical‐concerns‐about‐recent
• 4. Joseph‐Williams N, Edwards A, Elwyn G. Power imbalance prevents shared decision making. BMJ 2014; 348: g3178.
• 5. Edvardsson K, Mogren I, Lalos A, et al. A routine tool with far‐reaching influence: Australian midwives; views on the use of ultrasound during pregnancy. BMC Pregnancy Childbirth 2015; 15: 1–11.
• 6. Ravitsky V. The shifting landscape of prenatal testing: Between reproductive autonomy and public health. Hastings Cent Rep 2017; 47 (Suppl): S34–S40.
• 7. Juengst ET, McGowan ML. Why does the shift from “personalized medicine” to “precision health”; and “wellness genomics” matter? AMA J Ethics 2018; 20: E881–E890.
• 8. Hayward J, Chitty LS. Beyond screening for chromosomal abnormalities: advances in non‐invasive diagnosis of single gene disorders and fetal exome sequencing. Semin Fetal Neonatal Med 2018; 23: 94–101.